Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GPR84 | Q9NQS5 | 2/20 | 0.33 |
| ▸ | HTR2A | P28223 | 4/20 | 0.31 |
| ▸ | PDE4D | Q08499 | 1/20 | 0.30 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.30 |
| ▸ | HTR2C | P28335 | 1/20 | 0.30 |
| ▸ | HTR2B | P41595 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28291599 | 0.81 | POLB (0.37) | GPR84HTR2AFFAR1HTR2CHTR2B | |
| SCHEMBL27369292 | 0.78 | GPR84 (0.44) | GPR84HTR2AFFAR1HTR2CHTR2B | |
| SCHEMBL27906752 | 0.74 | FFAR1 (0.43) | GPR84HTR2AFFAR1HTR2CHTR2B | |
| SCHEMBL27771264 | 0.74 | HTR2A (0.44) | HTR2AHTR2CHTR2B | |
| SCHEMBL27524231 | 0.74 | NR4A2 (0.46) | GPR84HTR2APDE4DFFAR1HTR2C | |
| SCHEMBL27965809 | 0.74 | CYP2A6 (0.35) | GPR84HTR2AFFAR1HTR2CHTR2B | |
| SCHEMBL28678155 | 0.73 | HTR2A (0.45) | HTR2AHTR2CHTR2B | |
| SCHEMBL28044112 | 0.73 | RIPK1 (0.34) | HTR2APDE4DHTR2CHTR2B | |
| SCHEMBL27908791 | 0.72 | HTR2A (0.35) | GPR84HTR2AFFAR1HTR2CHTR2B | |
| SCHEMBL28818816 | 0.71 | SLC6A4 (0.39) | GPR84HTR2AFFAR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-1164574-C | Phenoxypropylamine compounds | ������ҩ��ʽ���� | 2004-09-01 | — | — | CN | disclosed |
| CN-1378533-A | Phenoxypropylamine compounds | MITSUBISHI PHARMACEUTICAL CO L (JP) | 2002-11-06 | — | — | CN | disclosed |